Company Profile
Genovis AB (publ.) develops and sells tools for the development of new treatment methods and diagnostics in North America, Europe, and Asia. The company provides FabRICATOR, FabALACTICA, FabRICATOR Z, GingisKHAN, FabULOUS (SpeB), a cysteine protease.
Its portfolio also includes FabDELLO, a protease that digests human IgG1, IgASAP, an IgA-digesting enzyme, and IgMBRAZOR, an IgM-specific protease GlySERIAS, an enzyme that digests flexible glycine-rich fusion protein linkers.
Its portfolio also includes GlyCLICK, a conjugation technology, TransGLYCIT, a platform technology, and GingisREX, a protease that digests proteins C-terminally of arginine residues.
Additionally, it offers OmniGLYZOR, a mixture of immobilized enzymes. Its portfolio also includes PNGase F, a glycoamidase, OpeRATOR, an O-glycan-specific protease, ImpaRATOR, an O-glycan-dependent protease, OglyZOR, an endoglycosidase, SialEXO, a sialidase product, FucosEXO, a mix of a-Fucosidases, GalactEXO, a ß-Galactosidase mix, GalNAcEXO, an a-N-Acetylgalactosaminidase, and GlycOCATCH, an affinity resin
GlycINATOR (EndoS2), an IgG-specific endoglycosidase. Its portfolio also includes IgGZERO (EndoS), an IgG-specific endoglycosidase, Anti-FabRICATOR (Anti-IdeS), a family of antibody products, and Anti-FabRICATOR Z (Anti-IdeZ), a goat polyclonal antibody SEQURNA RNase Inhibitor Thermostable.
Additionally, it offers antibodies, proteins, antigens, kits, and cell culture products. Its portfolio also includes bioprocess and gene therapy services, and services, such as SmartEnzymes fragmentation and conjugation, antibody LC-MS analysis, and customized antibody services. The company serves biotech and pharmaceutical, contract research, and contract manufacturing companies. Founded in 1999, the company is headquartered in Kävlinge, Sweden.